Humacyte
Global leader in engineering regenerative medicine products to save and improve patient lives. Learn more
Launch date
Employees
Market cap
AUD1.0b
Enterprise valuation
AUD923m (Public information from Sep 2024)
Share price
$5.34 HUMA
Durham North Carolina (HQ)
Authorizing premium user...